Melanotan II is a synthetic analog of alpha-melanocyte stimulating hormone (α-MSH) developed for research into UV-protective tanning via melanogenesis. Its non-selective melanocortin receptor activity produces a range of effects beyond pigmentation.
Research Applications
Melanogenesis/photoprotection research, appetite regulation, melanocortin receptor pharmacology, and body composition studies.
Dosage Information (Research Use)
Research protocols: Loading phase of 250-500 mcg/day subcutaneously, with maintenance at reduced frequency. UV exposure typically required for visible pigmentation effects. Research use only.
Reconstitution & Handling
Standard BAC water reconstitution.
Half-Life & Pharmacokinetics
Approximately 1 hour.
Reported Observations in Literature
Nausea (common, especially initially), facial flushing, appetite suppression, spontaneous arousal effects, mole darkening (existing nevi), and fatigue. Regular dermatological monitoring recommended in research contexts.
Key Research References
- Dorr RT, et al. “Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.” Life Sci. 1996